G70 | Myasthenia gravis and other myoneural disorders | |||||||
Excludes: | botulism
transient neonatal myasthenia gravis |
|||||||
G70.0 | Myasthenia gravis | |||||||
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced. | ||||||||
G70.1 | Toxic myoneural disorders | |||||||
Use additional external cause code (Chapter XX), if desired, to identify toxic agent. | ||||||||
G70.2 | Congenital and developmental myasthenia | |||||||
G70.8 | Other specified myoneural disorders | |||||||
G70.9 | Myoneural disorder, unspecified |
G71 | Primary disorders of muscles | |||||||
Excludes: | arthrogryposis multiplex congenita
metabolic disorders myositis |
|||||||
G71.0 | Muscular dystrophy | |||||||
Muscular dystrophy:
· autosomal recessive, childhood type, resembling Duchenne or Becker · benign [Becker] · benign scapuloperoneal with early contractures [Emery-Dreifuss] · distal · facioscapulohumeral · limb-girdle · ocular · oculopharyngeal · scapuloperoneal · severe [Duchenne] |
||||||||
Excludes: | congenital muscular dystrophy:
· NOS · with specific morphological abnormalities of the muscle fibre |
|||||||
G71.1 | Myotonic disorders | |||||||
Dystrophia myotonica [Steinert]
Myotonia: · chondrodystrophic · drug-induced · symptomatic Myotonia congenita: · NOS · dominant [Thomsen] · recessive [Becker] Neuromyotonia [Isaacs] Paramyotonia congenita Pseudomyotonia |
||||||||
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced. | ||||||||
G71.2 | Congenital myopathies | |||||||
Congenital muscular dystrophy:
· NOS · with specific morphological abnormalities of the muscle fibre Disease: · central core · minicore · multicore Fibre-type disproportion Myopathy: · myotubular (centronuclear) · nemaline |
||||||||
G71.3 | Mitochondrial myopathy, not elsewhere classified | |||||||
G71.8 | Other primary disorders of muscles | |||||||
G71.9 | Primary disorder of muscle, unspecified | |||||||
Hereditary myopathy NOS
|
G72 | Other myopathies | |||||||
Excludes: | arthrogryposis multiplex congenita
dermatopolymyositis ischaemic infarction of muscle myositis polymyositis |
|||||||
G72.0 | Drug-induced myopathy | |||||||
Use additional external cause code (Chapter XX), if desired, to identify drug. | ||||||||
G72.1 | Alcoholic myopathy | |||||||
G72.2 | Myopathy due to other toxic agents | |||||||
Use additional external cause code (Chapter XX), if desired, to identify toxic agent. | ||||||||
G72.3 | Periodic paralysis | |||||||
Periodic paralysis (familial):
· hyperkalaemic · hypokalaemic · myotonic · normokalaemic |
||||||||
G72.4 | Inflammatory myopathy, not elsewhere classified | |||||||
G72.8 | Other specified myopathies | |||||||
G72.9 | Myopathy, unspecified |
G73* | Disorders of myoneural junction and muscle in diseases classified elsewhere | |||||||
G73.0* | Myasthenic syndromes in endocrine diseases | |||||||
Myasthenic syndromes in:
· diabetic amyotrophy · thyrotoxicosis [hyperthyroidism] |
||||||||
G73.1* |
Eaton-Lambert syndrome
|
|||||||
G73.2* |
Other myasthenic syndromes in neoplastic disease
|
|||||||
G73.3* | Myasthenic syndromes in other diseases classified elsewhere | |||||||
G73.4* | Myopathy in infectious and parasitic diseases classified elsewhere | |||||||
G73.5* | Myopathy in endocrine diseases | |||||||
Myopathy in:
· hyperparathyroidism · hypoparathyroidism Thyrotoxic myopathy |
||||||||
G73.6* | Myopathy in metabolic diseases | |||||||
Myopathy in:
· glycogen storage disease · lipid storage disorders |
||||||||
G73.7* | Myopathy in other diseases classified elsewhere | |||||||
Myopathy in:
· rheumatoid arthritis · scleroderma · sicca syndrome [Sjögren] · systemic lupus erythematosus |